Alcon lines up product launches in India, bets on rising demand for advanced eye care

Major Major Mail Care is preparing to launch many products in India in the coming months, in response to the increasing demand for advanced eye technologies and strategic pushing to high -growth slices such as eye lens and refractive surgeries.

The company is awaiting regulatory approvals for many new launch operations that aim to improve surgeries and expand access to distinguished care solutions. “There are quite a few launch operations for this year. We are optimistic about obtaining regulatory approvals soon. Some of these innovations that will be presented for the first time in India,” Ammar Vias, Alcon India’s rural director, told Alcon India. Work today.

This launch pipeline is part of a broader strategy by Alcon to deepen its mark in the Indian Ophthalmology market, especially in the rapid expansion sectors such as the surgeries of the adequate operations and procedures for correcting vision.

The broader eye care market in India reflects a long -term positive look. According to Globenewswire, the value of the Indian vision market reached about 8,880 rupees ($ 1.07 billion) in 2024, and is expected to reach about 15,440 rupees ($ 1.86 billion) by 2033, as it grows with an annual CAGR growth rate of 6.31 percent. This growth is driven by increased awareness, high income levels, and the large burden of visual weakness in the country.

Alcon’s expansion in India is in line with these trends, especially since vision correction procedures such as LASIK become more common across the first and second level cities.

India is currently one of the best markets in the world in terms of growth rate. Fays said: “In India, the eye -lens surgery contributes approximately 65 percent of our work.” He said: “This is expected to grow because of drivers-aging and ambition. People in the fifties and sixties of the last century want to live free from the scene, so there is a mental transformation even with surgeries in the cataracts. Patients today choose distinct lenses.”

Alcon also sees a large head space for growth in the refractive sector – procedures that aim to correct vision and reduce dependence on glasses or contact lenses. The company is preparing to introduce Wavelight Plus, a technology of the next generation of LASIK that depends on the x -ray tracking algorithms, which Vyas believes will help in “creating a completely new category”.

“Wavelight Plus is a boom in correcting personal vision, designed for the younger generation who refuse to be limited by glasses. We are excited to present the latest Alcon innovations in correcting the vision in India. This launch also represents a new chapter in Alcon a long time ago to photograph it, where it was added to the production in full, which is said, which is said, which is said, which is said, This is what is said, which is said, which is said, which is said, which is said, which is said, which is said, which is said, received a positive response in the launch markets, and now Indian ophthalmologists who have experience with this technology share the same feelings.

Alcon achieved $ 2.1 billion of operational activities and reported the free cash flow of $ 1.6 billion in 2024. The company’s financial situation allows continuing to allocate capital to develop products, operational improvements, and the broader access to eye care services.

The eye care market in India is expected to grow by more than 8-10 percent, driven by increased awareness, high income levels and a large burden of visual weakness. Alcon is in line with this trend, especially since optional measures such as LASIK become more prevalent across the first and second level cities.

To support this expansion, Vyas said, Alcon continues to invest in its operations in India, not only in terms of product offers but also in the training infrastructure. The company runs Wet laboratories and skills transfer centers to train surgeons on advanced technologies and works with government plans to improve access in disadvantaged areas.

“We are working with government programs and non -governmental organizations to make surgeries in the cataracts easier, especially in rural areas.” “But our focus is also on quality – bringing better techniques and training surgeons so that patients have improved the results.”

Alcon Inc reported a fixed financial performance for the fiscal year 2024, which reflects its continuous focus on innovation and operational discipline. The company recorded net sales of $ 9.8 billion, an increase of 5 % over the previous year, or 6 % based on a fixed currency. This growth came from both surgical care and vision sectors. The operational income amounted to $ 1.4 billion, with an operating margin of 14.4 %, by improving 3.3 percentage points compared to the previous year. With the exception of the unexpected elements, the company reported a basic operational income of $ 2.0 billion, which led to a basic margin of 20.6 %.